The mortality rate for colon, rectum, and anus malignant neoplasms in Germany shows a decreasing trend from 2023, which stood at 29.8 deaths per hundred thousand, to 2028, with a slight decline from 29.6 in 2024 to 29.3 in 2028. The year-on-year percentage decrease is modest, indicating a gradual improvement in treatment or early detection. The last two years see a minor drop, while the compound annual growth rate (CAGR) over the next five years suggests continuous, albeit slow, progress.
Future trends to watch for include advancements in medical treatments, screening programs, and lifestyle changes, which could further accelerate the decline in mortality rates. Additionally, monitoring demographic shifts and healthcare policies will be key to understanding how they may impact future forecasts.
